Poland· PL-100313859
Viread
A tenofovir disoproxil product containing tenofovirum disoproxilum, registered in Poland by Gilead Sciences Ireland UC. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tenofovir disoproxil is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AF07 (tenofovir disoproxil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Tenofovir disoproxil · ATC J05AF07
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tenofovir disoproxil costs, country by country.
Normalised to the WHO defined daily dose (0.245 g), the median price runs from $0.24 in United States to $14.17 in Switzerland — a ×59 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Tenofovir disoproxil · price per daily dose (0.245 g)
USD · FX 28 Sept 2026
- CH Switzerland$14.17
- FR France$4.15
- US United States$0.24 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Tenofovirum disoproxilum
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Poland (PL)
- ATC code
- J05AF07
- ATC class
- Tenofovir disoproxil
- Defined daily dose
- 0.245 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for tenofovir disoproxil.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tenofovir disoproxil · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tenofovir disoproxil in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVIREADGilead Sciences Ireland UC, Carrigtohill
- FinlandVireadGilead Sciences Ireland UC
- BelgiumViread 123 mgGilead Sciences Ireland UC
- IrelandViread 123 mg film-coated tabletsGilead Sciences Ireland UC
- IcelandVireadGilead Sciences Ireland UC*
- SwedenViread 123 mg Filmdragerad tablettGilead Sciences Ireland UC
- FranceVIREAD 123 mg, comprimé pelliculéGILEAD SCIENCES IRELAND UC (IRLANDE)
- United Statestenofovir disoproxil fumarateMajor Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Tenofovir Disoproxil Accordpharma, Tenofovir Ratiopharm
- Bulgaria · Тенофовир Зентива, Тенофовир Полфарма
- Cyprus · Tenoviral
- Czechia · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Sandoz
- Germany · Tenofovirdisoproxil Accord, Tenofovirdisoproxil Al
- Denmark · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark
- Estonia · Tenofovir Disoproxil Sandoz
- Spain · Tenofovir Disoproxilo Accordpharma, Tenofovir Disoproxilo Aurovitas
- Finland · Tenofovir Disoproxil Hexal, Tenofovir Disoproxil Sandoz
- France · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Arrow
- United Kingdom (Northern Ireland) · Tenofovir Disoproxil, Tenofovir Disoproxil Accordpharma
- Greece · Agardon, Tenofovir Disoproxil Accord Pharma
- Croatia · Teynofor
- Hungary · Tenofovir Disoproxil Accordpharma, Tenofovir Onkogen
- Ireland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Teva
- Iceland · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
- Italy · Tenofovir Disoproxil Aurobindo, Tenofovir Disoproxil Doc Generici
- Liechtenstein · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
- Latvia · Tenofovir Disoproxil Teva
- Netherlands · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
- Norway · Filmdrasjerte Tabletter Viatris, Tenofovir Disoproxil Accordpharma
- Portugal · Tenofovir Accord, Tenofovir Aurobindo
- Romania · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
- Sweden · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be00030d-5fb2-4380-89ac-0559c28494d1 GET /v1/drugs/be00030d-5fb2-4380-89ac-0559c28494d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "123 mg",
"packaging": "Rpz ¦ EU/1/01/200/004 ¦ 90585\n1 butelka 30 tabl.\nRpz ¦ EU/1/01/200/005 ¦ 90586\n3 butelki 30 tabl.",
"substance": "Tenofovirum disoproxilum 123 mg",
"common_name": "Tenofovirum disoproxilum",
"pl_product_id": "100313859",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about tenofovir disoproxil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.